Guidelines include a standard evidence review and a set of recommendations for implementing the findings in clinical practice. Their defining feature is that they are developed in the context of a task force of key stakeholders.

• Management of Acute Lower GI Bleeding 01.09
• Inpatient Telemetry Monitoring: A Recommendation Statement from the University of Pennsylvania Health System Center for Evidence-based Practice 4.08
• Recombinant Factor VIIa for Uncontrolled Bleeding: A Recommendation Statement from the University of Pennsylvania Health System Center for Evidence-based Practice 3.08
• Selection and Initiation of Specialized Nutrition Support Therapy for the University of Pennsylvania Health System 3.08
• Transitions of Care for Patients on Anticoagulation: Recommendations of the Transitions of Care Subcommittee of the Anticoagulation Task Force in Collaboration with the UPHS Center for Evidence-based Practice 7.07 (Updated 2.08)
• Prophylaxis for Venous Thromboembolic (VTE) Disease in Inpatients: Recommendations of the VTE Prophylaxis Subcommittee of the UPHS Anticoagulation Taskforce in Collaboration with the UPHS Center for Evidence-based Practice 8.07
• Treatment of Venousthromboembolic (VTE) Disease in Inpatients: Recommendations of the VTE Treatment Subcommittee of the UPHS Anticoagulation Management Taskforce in Collaboration with the UPHS Center for Evidence-based Practice 4.07
• Use of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Inpatients 2.07
• Best Practices for the Inpatient to Outpatient Discharge Process 2.07
• Use of Drotrecogin Alfa (Activated protein C) for Adult Patients with Sepsis 1.07
• Aprotinin Use in Adult Cardiac Surgery (Aprotinin discontinued at UPHS on 11.8.07)

To view completed guidelines, please visit our intranet site or call or email Katie Thomas.